Related Experiment Video

Updated: Sep 27, 2026

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

Hyperhomocysteinemia and thrombosis

Ray Lee1, Eugene P Frenkel

  • 1Department of Internal Medicine, Division of General Internal Medicine, University of Texas Southwestern Medical School, 5323 Harry Hines Boulevard, Dallas, TX 75235-8889, USA. ray.lee@utsouthwestern.edu

Hematology/Oncology Clinics of North America
|March 12, 2003
PubMed

Insights

Homocysteine is a debated marker for vascular disease. While vitamin treatments can lower homocysteine levels, their clinical impact on reducing vascular disease requires further evidence from ongoing trials.

Area of Science:

  • Cardiovascular Science
  • Biochemistry
  • Genetics

Background:

  • Hyperhomocysteinemia is linked to vascular diseases like VTE, stroke, and CAD.
  • This association is not consistently supported by studies on genetic homocysteine metabolism variations.
  • Molecular studies suggest interactions between homocysteine, endothelium, and coagulation.

Purpose of the Study:

  • To investigate the role of homocysteine in vascular injury and thrombotic potential.
  • To determine if homocysteine is a marker or a pathogenic factor in vascular disease.
  • To evaluate the clinical impact of homocysteine-lowering vitamin treatments.

Main Methods:

  • Review of existing studies on homocysteine and vascular disease.
  • Analysis of molecular interactions involving homocysteine.
  • Observation of preliminary vitamin intervention trials.

Main Results:

  • Preliminary vitamin trials demonstrate effective homocysteine level reduction.
  • The clinical benefit of these treatments in decreasing vascular disease remains unproven.
  • Ongoing large-scale vitamin intervention trials are expected to provide crucial data.

Conclusions:

  • The role of homocysteine as a risk factor for vascular disease is still under investigation.
  • Evidence is needed to support routine testing and treatment of hyperhomocysteinemia.
  • Future vitamin intervention trials aim to establish evidence-based guidelines for managing homocysteine levels.

More Related Videos

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension05:57

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension

Published on: May 17, 2024

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...